Trial Profile
Comparison of long-term efficacies of entecavir and adefovir combination with entecavir alone in chronic hepatitis B patients refractory to adefovir and resistant to lamivudine
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Adefovir
- Indications Hepatitis B
- Focus Therapeutic Use
- 12 Dec 2015 New trial record